Oxygenta Pharmaceutical Limited
Oxygenta Pharmaceutical Limited is a Public Non-govt company company incorporated in 1990 and based in Telangana, India. Oxygenta Pharmaceutical Limited operates in Pharmaceuticals & Chemicals (NIC 24110) with authorized capital of ₹22.00 Cr and paid-up capital of ₹14.20 Cr. For 2018-19, the company reported revenue of ₹20.51 Cr and a net loss of ₹3.25 Cr. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
OXYGENTA PHARMACEUTICAL LIMITED is the legal entity of S S ORGANICS.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Oxygenta Pharmaceutical Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Oxygenta Pharmaceutical Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 377427829 | Axis Bank Ltd(Bank) | ₹12.00 Cr | 04 Jul 2021 | Satisfied |
| 350282146 | State Bank of India(Bank) | ₹5.65 Cr | 19 Sep 2019 | Satisfied |
| 399143677 | HDFC Bank Ltd(Bank) | ₹16.78 Cr | 27 Jan 2021 | Satisfied |
| 468550517 | HDFC Bank Ltd(Bank) | ₹8.79 Cr | 19 Sep 2019 | Open |
Charge IDs, lenders & amounts for Oxygenta Pharmaceutical Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2018-19 | — |
Detailed Financials
1 FYs| Line item | 2018-19 |
|---|---|
| Income statement | |
| Revenue from operations | |
| Other income | |
| Total income | |
| Total expenses | |
| Profit before tax | |
| Profit / (Loss) after tax | |
| Balance sheet | |
| Equity / Net worth | |
| Borrowings | |
| Current liabilities | |
| Total liabilities | |
| Current assets | |
| Cash & equivalents | |
| Total assets | |
| Employees | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹18.90 Cr | +33.4% | +16.0% | +18.5% |
| Profit after Tax | ₹1.94 Cr | +28.2% | +16.7% | +3.0% |
| Net Worth | ₹8.97 Cr | +6.8% | -4.5% | +3.1% |
| Employees | 356 | +15.9% | +18.9% | +19.3% |
Audited financials & ratios for Oxygenta Pharmaceutical Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2018-19 | -15.87% | — | — | -15.38% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 3,50,08,832 | 79.33% |
| Institutional Investors | 1 | 14,36,057 | 3.25% |
| Public & Others | 64 | 76,88,271 | 17.42% |
Promoter, institutional & public holding for Oxygenta Pharmaceutical Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
44 peersEvents & timeline
6External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.